Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea
· Delayed Price · Currency is KRW 1,155.00
+21.00 (1.85%)
At close: May 2, 2025, 3:30 PM KST
Wonbiogen Revenue
Wonbiogen had revenue of 8.26B KRW in the quarter ending March 31, 2025, with 16.74% growth. This brings the company's revenue in the last twelve months to 31.62B, up 9.45% year-over-year. In the year 2024, Wonbiogen had annual revenue of 30.44B with 2.79% growth.
Revenue (ttm)
31.62B
Revenue Growth
+9.45%
P/S Ratio
1.29
Revenue / Employee
416.10M
Employees
n/a
Market Cap
40.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 30.44B | 824.93M | 2.79% |
| Dec 31, 2023 | 29.61B | 2.87B | 10.72% |
| Dec 31, 2022 | 26.75B | 9.03B | 50.94% |
| Dec 31, 2021 | 17.72B | 5.70B | 47.46% |
| Dec 31, 2020 | 12.02B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| Samsung Biologics | 4,898.69B |
| LG Energy Solution | 25.76T |
| Hyundai Motor Company | 178.98T |
| Hanwha Aerospace | 15.28T |
| KB Financial Group | 14.93T |
| Kia Corporation | 109.25T |